Clinical Trials Logo

Filter by:
NCT ID: NCT05555862 Active, not recruiting - HPV Infection Clinical Trials

Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

anal HSIL HIV-
Start date: February 10, 2023
Phase: Phase 2
Study type: Interventional

This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)

NCT ID: NCT05555342 Active, not recruiting - Metastatic Cancer Clinical Trials

A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm

Start date: January 3, 2023
Phase: Early Phase 1
Study type: Interventional

This is a phase 0, pilot prospective study to determine the feasibility of combined irreversible electroporation (IRE) and radiation therapy in subjects with lung tumors with metastatic cancer of any histology. These are subjects who have advanced disease (stage IV) or previously treated disease that has become progressive, recurrent, or metastatic.

NCT ID: NCT05555043 Active, not recruiting - Endodontic Disease Clinical Trials

Comparison of Clinical Outcomes Between GentleWave® and Biolase®

Start date: November 8, 2022
Phase: N/A
Study type: Interventional

Introduction: In the US, 15 million root canal treatments (RCTs) are carried out annually. Success rates decrease with conventional chemo-mechanical root canal preparation techniques used on teeth with periapical radiolucencies associated with bacterial presence. New irrigation modalities, such as the GentleWave® System (GWS) and Waterlase iPlus® (WL), have been developed to overcome limitations and improve RCT success rates. Hypotheses: (1) GWS and WL provide superior clinical outcomes compared to conventional RCT using passive ultrasonic activation (PUI). (2) GWS and WL are acceptable treatment modalities for clinicians and patients. Aims: (1) Estimate probability of success of GWS, WL, and conventional RCT with PUI. (2) Evaluate clinician and patient experiences of the different techniques.

NCT ID: NCT05554614 Active, not recruiting - Clinical trials for High-risk Driving Events

Behind the Wheel (BTW) Smartphone Application

BTW
Start date: February 19, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if a phone app can help the learning-to-drive process among teenagers and novice drivers.

NCT ID: NCT05553925 Active, not recruiting - Obesity Clinical Trials

Partnerships for Reducing Overweight and Obesity With Patient-Centered Strategies 2.0

PROPS2
Start date: November 3, 2022
Phase: N/A
Study type: Interventional

The primary objective of the project is to adapt and implement a combined weight management intervention (an online program plus coaching and patient navigator support) across multiple settings and a diverse cross-section of patients and providers affiliated with Brigham and Women's Hospital (BWH). The overall goals of the proposed project are: 1. To improve management of overweight and obesity in clinical and community settings. 2. To improve outcomes among patients with overweight or obesity. To accomplish these goals, the investigators will engage with various stakeholders to adapt the combined intervention, implement the intervention across multiple settings and a diverse cross-section of patients and providers affiliated with BWH, evaluate the impact of the implementation, and create an implementation guide for dissemination. The specific aims of the proposed project are as follows: Aim 1: To continue to engage with patients, providers, and other stakeholders to adapt and integrate the intervention in a variety of clinical and community settings. Aim 2: To implement the intervention in a variety of patients and settings and to evaluate its impact on outcomes, using the RE-AIM framework. Aim 3: To evaluate maintenance of the intervention six months after formal implementation activities have ended, and to prepare a detailed implementation guide to help increase future reach and uptake.

NCT ID: NCT05553145 Active, not recruiting - Type 2 Diabetes Clinical Trials

The Prevalence of Autoimmune Antibodies in Patients With Type 2 Diabetes Managed by Endocrinology vs. Primary Care

Start date: September 1, 2022
Phase:
Study type: Observational

The purpose of this study is to assess the levels of autoimmune markers of diabetes in those with a type 2 diabetes diagnosis.

NCT ID: NCT05552508 Active, not recruiting - Asthma Clinical Trials

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

BURAN
Start date: October 11, 2022
Phase: Phase 4
Study type: Interventional

This study will assess the effects of benralizumab on airway dynamics in severe eosinophilic asthma in terms of quantitative computed tomography (CT)-derived measurements of pulmonary structure and function using the Functional Respiratory Imaging (FRI) platform.

NCT ID: NCT05551858 Active, not recruiting - Pain Clinical Trials

Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis

ProCP
Start date: November 17, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic pancreatitis is a rare but debilitating condition associated with chronic abdominal pain, diarrhea, diabetes, and an 8-fold increased risk for the development of pancreatic cancer. Unfortunately, there is no available treatment to prevent the progression of chronic pancreatitis, and most subjects require narcotic medications to control the pain. A receptor protein call the CCK-B receptor becomes activated in chronic pancreatitis and is in part responsible for the scar tissue or fibrosis that occurs and responsible for the cancer risk. In mice with chronic pancreatitis, the inflammation and damage was reversed with an old drug called proglumide that blocks the activation of the CCK-B receptor. Proglumide has also been shown to possibly reduce pain. This protocol involved a 2-Part study to test the safety of oral proglumide in those with confirmed chronic pancreatitis and the second goal is to determine if proglumide improves pain and function of the pancreas. Part-1 is an open-labelled Lead-in Study of N=8 subjects over a 12-week treatment period. Part-2 is a randomized double blind pseudo cross over study where subjects will be treated in Arm A (placebo for 12 weeks followed by 12 weeks of proglumide) and Arm B ( proglumide for 24 weeks).

NCT ID: NCT05551702 Active, not recruiting - Moderate Depression Clinical Trials

Treating Depression With Text Messaging

Start date: July 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the research study is to investigate whether CBT-txt, a counseling program delivered by text messages is effective in stopping or reducing depressive symptoms. CBT-txt is based on a counseling program that has been proven to reduce depression when delivered in-person and on the web, but has not yet been tested or shown to be effective when delivered by text.

NCT ID: NCT05551520 Active, not recruiting - Concussion Clinical Trials

ImPACT Version 4-Touchscreen: Normative and Reliability Study

Start date: February 7, 2022
Phase: N/A
Study type: Interventional

This research study is designed to establish normative database and reliability of ImPACT for adolescents and adults ages 12 through 80 to expand the use of devices to include touchscreen.